Effect of Cilostazol Treatment on Adiponectin and Soluble CD40 Ligand Levels in Diabetic Patients With Peripheral Arterial Occlusion Disease-Reference-Cited by-同舟云学术

Effect of Cilostazol Treatment on Adiponectin and Soluble CD40 Ligand Levels in Diabetic Patients With Peripheral Arterial Occlusion Disease

Published:2009 Issue:5 Volume:73 Page:948-954
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hsieh Ching-Jung¹,Wang Pei-Wen¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Chang Gung University College of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/73/5/73_CJ-08-0905/_pdf

Reference35 articles.

1. 1. Faglia E, Caravaggi C, Marchetti R, Mingardi R, Morabito A, Piaggesi A, et al, SCAR (SCreening for ARteriopathy) study group. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med 2005; 22: 1310-1314.

2. 2. Feringa HH, Karagiannis SE, Vidakovic R, Elhendy A, Schouten O, Boersma E, et al. Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease. Ann Vasc Surg 2007; 21: 780-789.

3. 3. Tseng CH. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients Angiology 2003; 54: 331-338.

4. Sex Difference in the Distribution of Atherosclerotic Risk Factors and Their Association With Peripheral Arterial Disease in Taiwanese Type 2 Diabetic Patients

5. 5. Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 2007; 384: 99-104.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation;International Journal of Molecular Sciences;2023-11-08

2. Effects of Cilostazol on Angiogenesis in Diabetes through Adiponectin/Adiponectin Receptors/Sirtuin1 Signaling Pathway;International Journal of Molecular Sciences;2022-11-27

3. Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease;Endocrinology and Metabolism;2022-04-30

4. Cilostazol for intermittent claudication;Cochrane Database of Systematic Reviews;2021-06-30

5. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target;International Immunopharmacology;2021-03